Torrent Pharma Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
2,672.00
2,352.00
1,847.00
1,225.00
1,526.00
1,186.00
Adjustment
996.00
993.00
937.00
1,349.00
992.00
876.00
Changes In working Capital
-480.00
418.00
-18.00
-351.00
-338.00
-385.00
Cash Flow after changes in Working Capital
3,187.00
3,764.00
2,766.00
2,224.00
2,180.00
1,676.00
Cash Flow from Operating Activities
2,585.00
3,266.00
2,368.00
1,802.00
2,005.00
1,392.00
Cash Flow from Investing Activities
-548.00
-159.00
-2,335.00
-196.00
-443.00
229.00
Cash Flow from Financing Activities
-2,297.00
-2,779.00
77.00
-1,781.00
-1,650.00
-1,549.00
Net Cash Inflow / Outflow
-261.00
326.00
110.00
-174.00
-89.00
73.00
Opening Cash & Cash Equivalents
835.00
508.00
398.00
572.00
661.00
588.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
573.00
835.00
508.00
398.00
572.00
661.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Torrent Pharma
Figures in Cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
2672.81
2916
-244.00
-8.34%
Adjustment
996.05
115
881.00
766.13%
Changes In working Capital
-480.93
-554
74.00
13.19%
Cash Flow after changes in Working Capital
3187.93
2477
710.00
28.70%
Cash Flow from Operating Activities
2585.11
1653
932.00
56.39%
Cash Flow from Investing Activities
-548.78
-804
256.00
31.74%
Cash Flow from Financing Activities
-2297.99
-799
-1,498.00
-187.61%
Net Cash Inflow / Outflow
-261.66
50
-311.00
-623.32%
Opening Cash & Cash Equivalents
835.14
363
472.00
130.07%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
573.48
413
160.00
38.86%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -20.85% vs 37.92% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
2,585.11
3,266.08
-20.85%






